2021 Investor Day

Leadership in OSA treatment with data applications ResMed myAir TM whipp Alanine and ancroid Realwed Продт day June 18- 91 kva Title 204 0 & Key differentiators AirView™ ResMed ResMed ResMed AirSION ResMed 2014. Eugene, Judy Las ResMad AirNew Patients Training for HME Training for Sleep Lab Main Men Heme User-friendly, intuitive platform provides milestone accomplishments and motivation to patients, increasing therapy adherence, and improving sleep quality Focused on app enhancements to enable long-term adherence for life vs. short-term (e.g., app-based nudges) Clear-cut market leader with 3.5M U.S. patients registered to the myAir platform across the website and app Recently launched upgraded version: myAir 2.0 © 2021 ResMed | 2021 Investor Day - Sept 8, 2021 Large installed base with over 16.5M patient enrolled in our cloud-based software solution Seamless integration with ResMed devices enhances provider efficiency and improves patient monitoring through industry-leading remote diagnostic tools Increased data capture enables us to drive more personalized care to improve the patient experience Unlocking value for both patients and providers 33

View entire presentation